Blood Biomarker Landscape in Patients with High-risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic Disease.
Clin Cancer Res
; 27(16): 4539-4548, 2021 08 15.
Article
in En
| MEDLINE
| ID: mdl-34112710
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thiohydantoins
/
Biomarkers, Tumor
/
Prostatic Neoplasms, Castration-Resistant
/
Androgen Antagonists
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2021
Document type:
Article